Abagovomab

· Menarini Group

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abagovomab, covering 2011-11-18 to 2011-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients [Phase 2, Phase 3]

See pricing